Kush Punyani

Biomimicking therapy for metabolic disorders

Diagonal Bio develops a ground-breaking platform for fast, simple and reliable pathogen diagnostics. The company was founded at the onset of the covid-19 pandemic in 2020 with the express goal to revolutionise diagnosis of infectious diseases. Diagonal Bio is led by COB Eva Nilsagård, CEO Jack Egelund Madsen, CSO Andreas Nyberg, and CFO Per Heander. Diagonals operations are based in Lund, Sweden and its scientific advisors include Prof. Vicent Pelechano (Karolinska Institute, Sweden), Prof. Christelle Prinz (Lund University, Sweden), Prof. Patrik Medstrand (Lund University), Prof. Tautgirdas Ruzgas (Malmö University, Sweden) and Kushagr Punyani (Spermosens AB). www.diagonalbio.com

Spermosens goal is to improve male fertility diagnostics and treatment through the introduction of ground breaking products. Spermosens first patented product JUNO-Checked measures the binding capacity between sperm and egg cell, which is a prerequisite for natural fertilization. The results are deemed to be able to help doctors choose the appropriate treatment method, which contributes to more successful IVF treatments, reduced suffering, and increased quality of life. The WHO estimates that more than 48 million couples are affected by infertility, half of which is caused in whole or in part by a male factor. The companys shares are listed on Spotlight Stock market. The shares have ISIN code SE0015346424 and are traded under the short name SPERM. For more information, see www.spermosens.com

We help entrepreneurs and early-stage companies develop and commercialize new ideas in life science; bringing together bright minds to share powerful ideas. Surrounded by smart and passionate people, as well as the best tools and approaches at your disposal – you’ll take leaps toward creating a business and connecting with the right people and resources. We offer business coaching, access to investor & industry networks, access to labs & instrument as well as a community with colleagues, friends and peers. Come join us!

Biomimicking therapy for metabolic disorders

A Challenge-driven Deeptech Venture Studio

Diagonal Bio develops a ground-breaking platform for fast, simple and reliable pathogen diagnostics. The company was founded at the onset of the covid-19 pandemic in 2020 with the express goal to revolutionise diagnosis of infectious diseases. Diagonal Bio is led by COB Eva Nilsagård, CEO Jack Egelund Madsen, CSO Andreas Nyberg, and CFO Per Heander. Diagonals operations are based in Lund, Sweden and its scientific advisors include Prof. Vicent Pelechano (Karolinska Institute, Sweden), Prof. Christelle Prinz (Lund University, Sweden), Prof. Patrik Medstrand (Lund University), Prof. Tautgirdas Ruzgas (Malmö University, Sweden) and Kushagr Punyani (Spermosens AB). www.diagonalbio.com

Developing low-energy, no-consumable water desalination platforms.